Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Wednesday, Anixa Biosciences' Director, Lewis H. Titterton, made a $131,907 buy of ANIX, purchasing 49,036 shares at a cost of $2.69 a piece. Anixa Biosciences Inc is trading down about 1.1% on the day Friday. Before this latest buy, Titterton bought ANIX on 4 other occasions during the past twelve months, for a total cost of $85,601 at an average of $3.10 per share.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.